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Abstract
Obtaining an appropriate laparoscopic workspace depends on several factors related to
the patient (i.e.,  weight and abdominal compliance) and the procedure (i.e.,  body’s
position, depth of anesthesia and intra-abdominal (IA) pressure). Among them, a deep
neuromuscular  blockade  (NMB)  contributes  to  provide  the  surgeon  with  better
operating conditions. This chapter discusses the interests and challenges of muscle
relaxation during gynecological laparoscopy. The introduction of sugammadex into
clinical practice provides the opportunity to modify the management of neuromuscular
blockade to improve the surgical conditions during laparoscopy as well as the safety of
the patients. The maintenance of a rocuronium-induced deep neuromuscular block
from the trocar insertion until the end of laparoscopy is no longer incompatible with
rapid recovery and awakening in optimal conditions.  Neuromuscular transmission
(NMT) monitoring is the key to adequate management and should be used in all cases.
Objective measurements allow for excellent intubation and surgical conditions, the
definition of thresholds and doses for the administration of reversal agents, and the
exclusion of residual blockade prior to the patient extubation.
Keywords: neuromuscular blockade, laparoscopic surgical conditions, rocuronium,
neostigmine, sugammadex
1. Introduction
Since the first laparoscopy was performed on a human by Jacobaeus in Sweden in 1910 [1],
laparoscopic techniques have steadily developed. It was not until 1943 that the first diagnostic
gynecological laparoscopy was performed with uterine mobilization, thanks to Raoul Palmer’s
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
ingenuity [2]. In the 1950s, with the advent of a safer laparoscopic lighting system, laparoscopy
had taken a step forward but remained mostly a diagnostic tool [3]. In 1982, the addition of a
video camera to laparoscopes allowed surgeons to be helped by assistants and to perform more
and more surgical techniques by laparoscopy (e.g., adhesiolysis, appendectomy, cholecystec-
tomy, and hysterectomy) [2, 3].
Diagnostic laparoscopy became part of fertility work-ups, with the growing development of
assisted reproductive technology (intrauterine inseminations and in vitro fertilization). When
cost-effectiveness debates began, routine diagnostic laparoscopy was increasingly supplanted
by these treatments. Nevertheless, surgical laparoscopy to treat advanced-stage endometriosis,
tubal pathology, and ovarian cysts or to perform myomectomy remains beneficial [4–7].
Relative limitations of performing surgical laparoscopy are surgeon expertise (in fertility
surgery), general anesthesia, patient obesity, cardiovascular disease (less frequent in young
patients receiving fertility treatments), and previous abdominal surgery [3–5].
In the last few years, new techniques emerged providing the surgeon with high precision and
less invasive tools (robotically assisted laparoscopy, single-port laparoscopy) [3, 8–11].
However, all laparoscopic procedures need to create a space inside the abdomen: the pneu-
moperitoneum.
2. The laparoscopic workspace
When insufflating the intra-abdominal (IA) cavity with gas, numerous elements contribute to
provide the surgeon with an adequate space to work. Some depend on the patient and others
on the procedure (Figure 1).
Figure 1. Contributing factors to the establishment of the laparoscopic workspace.
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2.1. Weight
When creating the laparoscopic workspace in overweight or obese patients, difficulties are
encountered due to the placement of laparoscopic trocars, with a higher risk of bleeding from
abdominal wall vessels due to a restricted operative field limited by the thick abdominal wall
or IA fat, and also due to limitations in placing obese patients in the Trendelenburg position
[3]. To decrease the risk of bowel injury during under-umbilical laparoscopic entry, different
techniques can be used: open under-umbilical laparoscopy or left/right upper-quadrant trocar
insertion [3, 12].
2.2. Previous abdominal surgery
Fibrosis and adhesions can be barriers to the creation of a large IA workspace.
2.3. Previous pregnancy or laparoscopy
On the contrary, a previous muscular stretching of the abdominal wall could have modified
the abdominal compliance in favor of larger IA volume [13].
2.4. Patient’s anatomy
Any IA tumor or organomegaly can constitute a threat for laparoscopic entry and adequate
workspace. In the case of huge or multiple fibroids (>10 cm in size), laparoscopic myomectomy
cannot be performed, and laparotomy is then indicated [12].
2.5. Depth of anesthesia and analgesia
Anesthesiologists are obligated to provide the patient with safe care during surgery. This
includes an adequate level of anesthesia and analgesia, considering the procedure require-
ments and the patient’s health status. The anesthesiologist must, in collaboration with the
surgeon, find the balance between benefits and harm of applying deep anesthesia during
laparoscopy to improve the quality of surgical conditions. Their common goal is to perform
safe and fast surgery under the best obtainable conditions.
2.6. The patient’s body position
The body position significantly influences the abdominal inflation volume and, thus, could
improve or worsen the surgical workspace. The mean inflated volume can be increased up to
900 mL in the Trendelenburg position and/or when the legs are slightly flexed at the hips [13,
14].
2.7. Intra-abdominal pressure (IAP)
Insufflating gas in the abdominal cavity during laparoscopy allows the creation of a workspace
between the abdominal wall and the IA organs, the pneumoperitoneum.
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The measurement of abdominal compliance makes it possible to estimate the required pressure
needed to achieve a certain IA volume and explain why certain patients have a limited
abdominal workspace compared with others during laparoscopy. The abdominal pressure-
inflated volume relationship behaves in a linear fashion between 0 and 12 mmHg. Every
abdomen can be described by two parameters: elastance and the pressure at zero volume [15].
In clinical practice, IAP is routinely monitored at 12–15 mmHg [16]. Low IAP is defined as 6–
10 mmHg [17]. Low IAP has potential benefits when compared with standard pressure:
• Fewer adverse effects on pulmonary function [18]. However, blood gas analyses and
pulmonary function tests are not significantly different. Healthy individuals, with the aid
of artificial ventilator adjustments, are able to compensate for pulmonary function reduction
during pneumoperitoneum [17]. Further studies are necessary for ASA three to four
patients.
• Fewer hemodynamic side effects are encountered, including reduced preload and decreased
cardiac output [19], but this does not seem to have significant advantages when compared
with standard IAP in healthy patients [17].
• No significant or persistent liver (transient elevation of liver enzymes such as AST and ALT)
or renal impairment (reduced renal perfusion, decreased urine output, but no changes in
postoperative creatinine) was observed or had clinical consequences in healthy patients [17].
• Postoperative peritoneal adhesions and anastomotic leakage are important complications
following gynecological and abdominal surgery. The mechanism is unclear but could
include local hypoxemia caused by mechanical compression of the capillary bed reducing
blood flow. Local hypercapnia induces acidosis and an impaired microcirculation [17]. One
human study suggests that low IAP minimizes the adverse effects on surgical peritoneal
environment [20].
• As with the head-down position, elevated IAP increases intrathoracic pressure, reduces
cerebral venous drainage, and increases cerebrospinal fluid and subsequently intracranial
and intraocular pressure [17].
• Low IAP is associated with significantly lower postoperative inflammatory response of IL2,
IL6, and CRP [17, 21]. This has to be confirmed by further studies.
• Low IAP was associated with less postoperative pain during the early postoperative phase
[22–24], including less shoulder referred pain [25–27]. This was also demonstrated after
laparoscopic gynecologic procedures [28, 29]. Extended wash out of IA gas (5 min with open
valve umbilical trocar after lap hysterectomy) was found to be an effective and safe method
of reducing postoperative abdominal and shoulder pain levels [30].
A clinically significant reduction in pain score is likely to result in shorter hospital stays and
earlier return to normal activity and work [31]. However, the difference in pain intensity
between low and standard IAP was not always immediately significant, only after 2–3 days
[17]. In addition, the reduction in postoperative analgesic requirement was not always
relevant [22, 32]. Factors implicated in pain after laparoscopic surgery include diaphragm and
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phrenic nerve irritation or stretching, intraperitoneal acidosis, residual IA gas, volume and
lack of humidity of the insufflated gas, wound size and the presence of drains, and also
sociocultural and individual factors [31, 33, 34].
On the other hand, low IAP was often associated with a substantial reduction in visibility and
available working space [35]. Then, decreasing IA pressure might prolong operation time and
subsequently increase the costs of the procedure; this was not found to be significant [36]. Low
pressure apparently resulted in a less than optimal surgical field, which could result in an
increased incidence of surgical complications. However, low IAP had a comparable incidence
of serious adverse events and conversions to open procedures when compared with standard
pressure [28, 37, 38].
Finally, recommendations to use low IAP are weak, and more studies are required to establish
the safety of low-pressure pneumoperitoneum and to explore its value for physicians and
patients [17]. A practical and reasonable approach is to start with the lowest possible IAP that
is required to obtain adequate exposure of the operative field [39] and to increase the pressure
to routine level when the exposure is inadequate [40].
2.8. Is there a place for deep neuromuscular blockade (NMB) to improve the laparoscopic
workspace and surgical conditions?
Neuromuscular blocking agents (NMBAs) were introduced into clinical practice in 1942 and
were rapidly adopted as an important part of modern balanced anesthesia [41]. At a time when
anesthesia was tricky in most patients, inducing a NMB significantly improved surgical
conditions in more and more situations [42]. However, almost as soon as its use began, NMBA
administration was associated with side effects and related mortality [43].
To secure the airway, orotracheal intubation is traditionally performed after injecting a NMBA.
Compared with other techniques, excellent intubating conditions are more easily obtained
with NMB and are less frequently associated with postoperative hoarseness and vocal cord
injuries [44].
Classically, administering NMBA continuously during some surgical procedures may enhance
patient safety and decrease morbidity (e.g., open eye surgery under general anesthesia and
intracranial surgery) [31], but new indications emerged with the development of surgery,
including laparoscopy [45]. The major determinant of the amount of pressure that is required
for adequate surgical conditions is the compliance of the abdominal wall, which could be
increased significantly by the administration of NMBA [17]. Madsen and colleagues also
suggest that the possible negative effects of low-pressure pneumoperitoneum on perioperative
conditions might be overcome by the adequate use of NMBA [46].
The goal of this chapter is to provide the reader with the factors that help to determine the
benefits and challenges of maintaining a deep NMB during pelvic laparoscopy to improve the
surgical workspace and the operating conditions.
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3. Neuromuscular transmission: physiology and monitoring
The neuromuscular junction is the chemical step that transduces the electrical activity of a
motor nerve ending to the postjunctional muscle membrane to ultimately generate muscle
contraction (Figure 2a). The presynaptic nerve ending is responsible for acetylcholine (ACh)
synthesis, packaging into vesicles, and release when the nerve membrane depolarizes. The
synaptic cleft allows for rapid diffusion of the neurotransmitter. The postsynaptic membrane
is a specialized region of folded muscle membrane filled with nicotinic acetylcholine receptors.
Two acetylcholine molecules have to fix on the nicotinic receptor to open its ionic channel and,
when numerous enough, induce the muscle membrane depolarization and the propagation of
the electric signal, which generate the muscle contraction. ACh is rapidly inactivated and
divided into acetate and choline by acetylcholinesterases present in the postsynaptic mem-
brane folds. A presynaptic mechanism allows for sustained transmitter release over time to
maintain the muscle contraction. When stimulated by ACh, slightly different nicotinic
receptors present on the presynaptic nerve terminal mobilize storage vesicles to reach the nerve
membrane and release a higher quantity of ACh in the synaptic cleft. This positive feedback
mechanism allows for high intensity and long-duration muscle contraction [47].
Figure 2. Neuromuscular transmission (a) and blockade (b). (a) The motor nerve (on the left) synthetizes, stores, and
liberates vesicles of acetylcholine in the synaptic cleft when it depolarizes. Acetylcholines (yellow stars) bind to postsy-
naptic nicotinic receptors to open the ionic channel and depolarize the muscle membrane (on the right), inducing the
muscle contraction. Cholinesterases inactivate rapidly acetylcholine in the folds of the motor end plate. Presynaptic
nicotinic receptors allow for a positive feedback on the nerve in order to liberate more acetylcholine to induce intense
contraction. (b) Neuromuscular blocking agents (black trapezes) distribute from the plasma into the synaptic cleft to
bind and inactivate the nicotinic receptors on pre- and postsynaptic membranes, competitively with acetylcholine.
Non-depolarizing neuromuscular blocking agents (NMBA) fix competitively with ACh on
nicotinic receptors. On presynaptic receptors, for which they have the highest affinity, they
prevent the mobilization and release of storages of ACh, inducing fade to repetitive nerve
stimulation because of a lack of available ACh. On the postsynaptic receptors, they prevent
the membrane from depolarizing and, therefore, initiating the muscle contraction. The NMB
is a combination of these two actions (Figure 2b).
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According to the pharmacokinetics of each drug, NMBA is metabolized and/or progressively
eliminated from the plasma. The concentration decreases in the synaptic cleft and, as ACh can
reach more and more receptors, the neuromuscular transmission (NMT) recovers gradually.
During anesthesia, the level of NMB can be monitored with the use of a nerve stimulator
(Figure 3). As the standard, the ulnar nerve is stimulated at the wrist and the degree of
relaxation is measured at the adductor pollicis muscle [48]. The motor nerve is stimulated by
standardized electric patterns:
Figure 3. Neuromuscular transmission monitoring. The ulnar nerve is electrically stimulated at the wrist by train of
four (TOF) or post-tetanic count (PTC) sequences. The thumb movements are recorded and displayed during the onset
(after neuromuscular blocking agent administration: black arrow) and spontaneous recovery of a neuromuscular
blockade: vertical lines represent the first twitch height (T1), purple dots are the TOF ratio (T4/T1), PTC and TOF count
are additionally represented. Deep neuromuscular blockade is defined as TOF count 0 and PTC ≥ 1.
• The train-of-four (TOF) [49] is an automatic repetition of four square electric twitches (200
µs) at 2 Hz for every 15 s. The current intensity can be set according to every patient
characteristic (50–60 mA as the default level). During NMB recovery and related to presy-
naptic fade, TOF recovers progressively 1, 2, 3, and then 4 counts before a TOF ratio (relative
height of T4/T1) can quantify the residual fade until reaching 1.
• When there is no response to TOF, the post-tetanic count (PTC) [50] is another automatic
sequence dedicated to monitoring deeper levels of blockade, including a tetanic stimulation
(twitches at 50–100 Hz during 5 s) to mobilize presynaptic storages of ACh before 20 single
twitches (1 Hz) are delivered.
The corresponding muscle responses are evaluated by the operator (visual or tactile subjective
evaluation) or, much better, are objectively quantified by a dedicated monitor. Then, the
complete course of any NMB can be accurately described by PTC, TOF count, and TOF ratio.
Unfortunately, many clinicians still do not use objective monitors in their clinical practice [51].
This is undoubtedly a prerequisite to proper intraoperative management of NMB.
According to PTC, TOF count, and TOF ratio, different levels of NMB are determined as
follows: [31, 48]
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• Intense block: no response to PTC.
• Deep NMB: a PTC one or more but no response to TOF.
• Moderate block: TOF count 1–3.
• Shallow block: a TOF count of 4 with fade, quantified as TOF ratio.
• Threshold for safe tracheal extubation: TOF ratio >0.9.
It is important to know that different muscle groups have different sensitivities to NMBAs [52,
53]. Particularly, the adductor pollicis muscle is more sensitive to NMBAs compared with the
abdominal wall muscles and the diaphragm, which have a more rapid recovery [54–56].
Consequently, the depth of blockade at the thumb does not reflect the exact level of blockade
at the other muscle groups. Even when no TOF count is recorded at the thumb, laparoscopic
surgeons may experience insufficient relaxation of the abdominal wall muscles that could
induce unexpected movements of the IA instruments and could impair the surgical conditions.
On the other hand, using PTC allows for properly monitoring deep NMB at the thumb and is
sufficiently sensitive to ensure enough diaphragm paralysis for most clinical purposes [57, 58].
4. Neuromuscular blockade: the impact on laparoscopic workspace
Modern anesthesia provides every patient undergoing laparoscopic surgery with a combina-
tion of drugs and techniques as closely adapted to his physical status as possible, including
hypnotic agents, multimodal analgesia, lung ventilation in head-down position, hemodynam-
ic and fluid management, and postoperative nausea prevention. Among them, NMB is
indicated for intubation and during the surgical procedure. But, as do most drugs, NMBAs
have some risks related to their administration, including:
• Anaphylaxis (1/13,000, depending on the drug). Anesthesiologists are trained to manage
this acute complication (protocol, algorithm, and simulation).
• Awareness during the procedure. Monitoring of the depth of anesthesia continues to
improve, including using the bispectral index, which helps to prevent awareness during
anesthesia [59].
• Residual paralysis at the time of tracheal extubation (see Section 5).
As a consequence, some anesthesiologists might be reluctant to induce deep NMB, especially
during the entire procedure. Satisfactory surgical conditions are the end product of multiple
factors that may range from the level of general anesthesia administered to the skill of the
surgeon and the collaboration between the surgeon and the anesthesiologist [60]. In clinical
practice, when a surgeon experiences surgical conditions that are less than satisfactory, the
anesthesiologist can take some of the following actions [61]:
• Changing the body position.
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• Increasing the depth of anesthesia (high dose of hypnotics, vapors, and/or opioids).
• Changing the ventilator patterns.
• Increasing the insufflation pressure.
These alternatives often cause cardiovascular depression and increased peak airway pressure
and cannot reliably abolish all movements [62, 63]. Without appropriate NMB, sudden muscle
contractions are experienced in ±30% of laparoscopic procedures [64, 65]. The initial (blind)
insertion of the trocars is a high-risk part of the laparoscopic procedure that could cause the
most serious complications related to laparoscopy, such as perforations of a bowel or a large
vessel [66]. The establishment of a deep NMB in this initial part of the procedure seems to be
essential to reduce the possible occurrence of these complications. However, no study actually
demonstrates that maintaining a deep NMB reduces the surgical complication rate [60], and
NMB should not be used as a substitute for adequate depth of anesthesia [31].
Ultimately, what level of NMB is associated with optimal conditions for laparoscopic surgery,
and does a deep NMB provide superior operating conditions for laparoscopy than does a
moderate block?
4.1. Studies to determine the interest of deep NMB during pelvic laparoscopy
The requirement for muscle relaxation has evolved with the development of surgery. Few
studies addressed this question in the specific field of gynecologic laparoscopy. Different
methods were used, making comparison difficult and inducing a risk of bias in the interpre-
tation of the results. The most frequent outcome was the subjective surgeon’s assessment of
the surgical conditions during the procedure [61]. Different surgical rating scales (SRSs) (three
to five points) were used to quantify the quality of the surgical field and the operating
conditions, ranging from excellent to poor or unacceptable. However, these scales have not yet
been validated for assessment of surgical conditions.
To enable the reader to come to his own conclusion, the different studies available in pelvic/
gynecological laparoscopic surgery are summarized in Table 1 given below [65, 67–73].
Authors, year, reference
Type of surgery, n
NMB design
Method of evaluation
Relevant results concerning surgical
conditions
Bertrand et al. (1983) [67]
Various gynecological lap,
n = 40
Succinylcholine 1 mg kg−1 + infusion or
vecuronium 0.05–0.06–0.07 mg kg−1
SRS 4 grades
Better muscle relaxation, less supplemental
vecuronium and less IAP with
succinylcholine or 0.07 mg kg−1
vecuronium.
Swann et al. (1993) [68]
Various gynecological lap,
n = 60
Atracurium 0.3 mg kg−1 (TT) versus no
NMB (LMA).
SRS 3 grades
Two poor conditions in the no NMB group
(vs 0 in Atracurium group), but concluded
as not clinically different.
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Authors, year, reference
Type of surgery, n
NMB design
Method of evaluation
Relevant results concerning surgical
conditions
Chassard et al. (1996) [69]
Various gynecological lap,
n = 50
Atracurium 0.25 mg kg−1 + boluses to
maintain T1 < 10% versus no NMB.
SRS 4 grades
The operating conditions were not
influenced by NMB.
Williams et al. (2003) [70]
Day case gynecological lap,
n = 40
Atracurium 0.5 mg/kg (TT) supple
mented as required, versus no NMB
(LMA).
SRS 4 grades
Better adequacy of pneumoperitoneum
with NMB; 28% inadequate trocar insertion
in the no NMB group
Paek et al. (2009) [71]
Pelvic laparoscopy,
n = 56
Rocuronium 0.6 mg kg−1 + 0.15 mg kg−1
boluses to maintain TOF count ≤ 2
versus no additional bolus.
Events, IAP
No coughing, bucking or movement during
procedures.
No supplemental NMBA required during
propofol remifentanil anesthesia.
Chen et al. (2013) [72]
Gynecological lap,
n = 120
Rocuronium 0.6 mg kg−1 versus no
NMB. LMA in all cases.
Surgeon’s questionnaire
Comparable surgical conditions. No benefit
of NMB during anesthesia with LMA.
Dubois et al. (2014) [65]
Lap hysterectomy,
n = 100
Rocuronium 0.6 mg kg−1 + 5 mg boluses
to maintain TOF count ≤ 2 versus
shallower NMB.
SRS 4 grades
Deep NMB provided better (excellent)
surgical conditions when TOF count = 0
and prevented unacceptable conditions
(28% in shallow NMB).
Madsen et al. (2015) [73]
Gynecologic lap,
n = 14
Rocuronium 1 mg kg−1 deep NMB
versus no NMB.
SRS 4 grades
Distance from sacral
promontory to
the trocar
Slightly improved workspace and better
conditions during suturing of the fascia
with deep NMB.
Table 1. Studies investigating the interest of neuromuscular blockade during gynecological laparoscopic surgery.
Overall, there is good evidence that NMB optimizes surgical conditions in gynecological
laparoscopy. This was also true during laparoscopic prostatectomy and nephrectomy. Deep
NMB seems superior to moderate NMB [61, 74, 75].
In addition, when compared to moderate NMB (or no NMB) during upper abdominal
laparoscopy, deep NMB marginally optimizes surgical conditions and allows the IAB pressure
to be reduced by 3–5 mmHg without compromising surgical conditions [61, 76].
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It seems useful to establish a deep NMB from the beginning of the procedure instead of waiting
for the surgeon to request it [46]. The main problem is the residual block at the end of surgery
and the time needed to recover before being able to extubate the patient. This issue is addressed
in the following section.
5. The residual neuromuscular blockade after surgery
Any administration of a NMBA during general anesthesia carries the risk of residual effects
after surgery. This becomes inevitable when maintaining the NMB deep until the end of the
surgical procedure. Based on numerous studies, postoperative residual NMB is defined as a
TOF ratio <0.9 [77, 78]. Its incidence when arriving in the post-anesthesia care unit (PACU) is
estimated to be approximately 40% of the patients who received NMBA in clinical practice.
Residual NMB has clinical consequences and complications that can prolong hospitalization.
Before reaching the safety threshold of TOF ratio >0.9, the most frequent adverse events include
patient anxiety, upper airway collapse because of the high sensitivity of pharyngeal muscles
to NMBA [79], hypoxia because of the decreased sensitivity of chemoreceptors [80], and
dysphagia and reduced protection against aspiration increasing the risk of postoperative
pneumonia [81]. For these reasons, guidelines should be observed to rule out any level of
residual NMB before awakening and extubating the patient. Current recommendations are to
use short- or intermediate-acting NMBAs, to routinely reverse all NMB, and to monitor
neuromuscular transmission whenever relaxants are used, especially before and after NMB
reversal [82–84]. By decreasing the incidence of the residual NMB in the PACU, patient safety
is improved, as is demonstrated by the reduction in postoperative respiratory complications
[85].
5.1. Quantitative neuromuscular transmission monitoring in daily practice
The use of neuromuscular transmission (NMT) monitoring is mandatory to manage deep
NMB and to determine the threshold for the administration of the appropriate doses of reversal
agents and, finally, to confirm their effect until attaining a TOF ratio >0.9. Unfortunately, visual
or manual evaluation of the contraction intensity induced by the nerve stimulation does not
allow for the effective quantification of the relative force of the successive muscular responses
and, consequently, lacks accuracy and cannot exclude significant levels of residual NMB [86].
The recommendation is to use objective measures to confirm NMB recovery at a minimum of
a TOF ratio of 0.9 before extubating the patient [83]. Measurements obtained by recording
techniques (i.e., the application of custom sensors) using the principles of acceleromyography,
kinemyography, or electromyography have proved their effectiveness, with some specific
precautions [82, 87–89]. Implementing these quantitative monitors to manage every NMBA
administration in daily practice demonstrated a reduction in the residual NMB incidence to a
very low level [90].
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5.2. Pharmacological reversal of the residual NMB
• Neostigmine antagonizes a non-depolarizing NMB by increasing the availability of acetyl-
choline (ACh) in the synaptic cleft, tipping the competitive balance in favor of the neuro-
transmitter primarily by inactivating the acetylcholinesterases at the muscle endplate
(Figure 4a).
Administered routinely at the end of anesthesia, neostigmine has demonstrated a positive
effect on postoperative mortality [91]. Beyond this favorable overall trend, the effectiveness of
NMB reversal with neostigmine is limited by several specific problems.
Figure 4. Reversal agents. (a) Neostigmine inhibits cholinesterase making more acetylcholine available in the synaptic
cleft. The competitive block evolves in favor of the acetylcholine and neuromuscular transmission increases gradually.
Neuromuscular blocking agents still present are progressively eliminated according to their pharmacokinetic proper-
ties. (b) Sugammadex encapsulates rocuronium in the plasma, washing the synaptic cleft of all neuromuscular block-
ing agents for good. Normal neuromuscular transmission recovers rapidly.
Even the maximal recommended dose of 70 µg/kg (or 5 mg) has limited effects and cannot
effectively reverse deep levels of NMB [92]. Neostigmine can only be administered from a
moderate block with a minimum TOF of 3 to increase efficacy and safety [93, 94]. Moreover,
the delay needed for reversal with neostigmine (10–15 min on average) has a large interindi-
vidual variability. Patients might need more than 60 min to reach a TOF ratio of 0.9 [95]. The
problem is that most anesthesiologists will not wait long enough before extubating their
patients. Consequently, even when routinely administered, neostigmine is frequently
insufficient to completely reverse the residual NMB at the time of tracheal extubation [96]. The
risk of residual blockade without quantitative NMT monitors is significant. Even when using
a peripheral nerve stimulator with subjective (visual or tactile) evaluation, more than 50% of
the patients could experience residual NMB after the administration of neostigmine [97]. Then,
only the proper use of neostigmine guided by NMT monitors can help eliminate postoperative
respiratory complications associated with the use of NMBA [82, 83, 98].
Because neostigmine is an acetylcholinesterase inhibitor, it induces ACh stimulation on
muscarinic receptors in smooth muscles, the heart and various glands and nicotinic receptors
in the autonomic ganglia, which induce adverse side effects including postoperative nausea
and/or vomiting, bradycardia, prolonged QT interval, unpredictable bronchoconstriction,
ptyalism, and increased intraluminal pressure and propulsive activity in the bowels [99]. To
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prevent some of these side effects, parasympathicolytic drugs (atropine or glycopyrrolate) are
administered simultaneously. These compounds are also accompanied by potential secondary
effects (i.e., tachycardia, urinary retention, accommodation disorders, and dry mouth).
Because of the limited ability of anticholinesterases to antagonize deep NMB, most clinicians
wisely attempt to avoid deep block as the end of surgery approaches, exposing the surgeon
and the patient to impaired surgical conditions. But recently with the availability of sugam-
madex as an alternative to neostigmine, there has been renewed interest in other potential
indications for the intraoperative maintenance of deep NMB, especially for laparoscopic
surgery [31].
• Sugammadex is a selective relaxant-binding agent [100]. The modified gamma-cyclodextrin
encapsulates the steroidal NMBAs rocuronium or vecuronium present in the plasma and
the neuromuscular synaptic cleft. The concentration of the free steroidal NMBA is rapidly
reduced. The nicotinergic receptors again become available to ACh, and the NMB fades
rapidly (Figure 4b). The steroidal NMBA-sugammadex complexes remain bound until they
are excreted by the kidneys. Because of the molecular selectivity for steroidal NMBAs,
sugammadex has no effect on the benzylisoquinolines (atracurium, cisatracurium, and
mivacurium).
Different doses of sugammadex have been determined to guarantee effective reversal accord-
ing to the depth of the NMB (according to the plasma concentration of the steroidal NMBA)
[101]. A dose of 4 mg/kg is indicated to reverse deep NMB within a few minutes (Figure 5). It
is not only much faster and more predictable than neostigmine, but it is also able to reverse all
depths of blockades [95, 101]. In addition, sugammadex has an excellent clinical tolerance, few
side effects, and it is beneficial for numerous categories of patients who are at a particular risk
for developing complications from residual NMB or for undesirable effects from neostigmine
[45, 101].
Figure 5. Deep NMB during the entire laparoscopic procedure. Following rocuronium administration (black arrow), a
deep neuromuscular blockade is maintained until the end of surgery. Then, sugammadex (orange arrow) allowed for a
fast and complete reversal.
As an innovative drug, sugammadex is expensive when compared with most drugs used in
anesthesia. Intraoperative maintenance of deep NMB and sugammadex reversal have impor-
tant economic repercussions that could call into question the routine use of deep NMB for
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laparoscopic surgery [60]. On the other hand, every minute of open operating theater time has
a high financial value [102]. A few minutes spared with a faster and more predictable reversal
strategy allowing for a shorter operating room discharge can balance the cost of the new drug
and contribute to optimization of operating theater turnover and overall financial return [103].
6. Conclusion
The introduction of sugammadex into clinical practice provides the opportunity to modify the
management of NMB to improve the surgical conditions during laparoscopy as well as the
safety of the patients. The maintenance of a deep rocuronium induced NMB from the trocar
insertion until the end of laparoscopy is no longer incompatible with rapid recovery and
awakening in optimal conditions. In all cases, NMT monitoring is the key to adequate NMB
management. Objective measurements allow for excellent intubation and surgical conditions,
the definition of thresholds and doses for the administration of reversal agents, and the
exclusion of residual NMB prior to the patient extubation.
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